Advertisement
Advertisement
U.S. Markets close in 4 hrs 27 mins
Advertisement
Advertisement
Advertisement
Advertisement

iSpecimen Inc. (ISPC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.6500+0.1000 (+3.92%)
As of 04:00PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.5500
Open2.5800
Bid2.6200 x 900
Ask2.8400 x 900
Day's Range2.5400 - 2.6800
52 Week Range2.0700 - 28.9800
Volume46,301
Avg. Volume430,577
Market Cap23.133M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    iSpecimen Presents New Research to Optimize Biobanking at International Society for Biological and Environmental Repositories 2022 Annual Meeting

    Company Gave Three Presentations, Including Oral Discussion on How New Technology Can Support the “Just-in-Time” Approach to Biobanking LEXINGTON, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), a global online marketplace that connects scientists in need of biospecimens for medical research with healthcare organizations that can provide them, announced today that the Company gave three presentations at this year’s International Society for B

  • GlobeNewswire

    iSpecimen to Participate in the H.C. Wainwright Global Investment Conference on May 23-26, 2022

    LEXINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate virtually in the H.C. Wainwright Global Investment Conference to be held on May 23-26, 2022. Dr. Ianelli's corporate presentation will be a

  • GlobeNewswire

    iSpecimen Reports First Quarter 2022 Financial and Operating Results

    - Recently Launched Enhanced iSpecimen Marketplace Platform to Help Scientists More Efficiently Search for Biospecimens -LEXINGTON, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three-month period ended March 31, 2022. “Our team has been

Advertisement
Advertisement